Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Florida Department of Health opposing Florida’s proposed revisions to Rule 64D-3.046, related to immunization requirements for school entry.
Tallahassee, FL. – Following Florida Senate Appropriations Committee’s 10–7 vote to advance SB 1756 yesterday; the Americ
Tallahassee, FL. – Following Florida Senate Appropriations Committee’s 10–7 vote to advance SB 1756 yesterday; the Americ
The American Cancer Society Cancer Action Network (ACS CAN) and the American Heart Association (AHA) are joining forces to support a proposed ballot initiative allowing voters to decide whether Florida should expand Medicaid. Florida Decides Healthcare, the coalition leading the signature collection efforts, is determined to collect the million signatures needed to add a question on the 2028 ballot asking voters whether the state should expand Medicaid.
As lawmakers head into the 2026 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Floridians and expand access to care.
Las vacunas son una parte fundamental de la atención para las personas con cáncer y sus familiares. ACS CAN aboga por políticas con base científica que mejoren el acceso a las vacunas que previenen y tratan el cáncer, además de proteger a las personas que viven con esta enfermedad.
“For cancer patients, these health care tax credits are a lifeline that enables access to timely, life-saving treatments,” said Susan Harbin, Senior Government Relations Director for ACS CAN Florida and recent Field Government Relations Professional of the Year.
Washington, D.C., – September 17, 2025 – Susan Harbin was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocating for cancer-fighting public policies.
Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) reveló que más del 70% de las pacientes con seguro médico comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento para el cáncer de mama en 2023.
TALLAHASSEE, Florida – Mientras los legisladores de Florida comienzan las reuniones de los comités para la sesión de 2025, la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) les pide que prioricen la reducción del s